KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $4.03 $5.34 Friday, 26th Apr 2024 BCRX stock ended at $4.16. During the day the stock fluctuated 3.40% from a day low at $4.12 to a day high of $4.26.
90 days $4.03 $6.35
52 weeks $4.03 $9.07

Historical BioCryst Pharmaceuticals prices

Date Open High Low Close Volume
Jun 11, 2020 $4.57 $4.62 $4.22 $4.23 5 449 148
Jun 10, 2020 $4.44 $4.65 $4.35 $4.57 6 484 262
Jun 09, 2020 $4.38 $4.41 $4.22 $4.31 4 582 977
Jun 08, 2020 $4.31 $4.55 $4.22 $4.40 6 860 112
Jun 05, 2020 $4.34 $4.40 $4.07 $4.17 8 047 190
Jun 04, 2020 $4.44 $4.65 $4.33 $4.36 5 930 356
Jun 03, 2020 $4.69 $4.75 $4.49 $4.50 5 183 704
Jun 02, 2020 $4.73 $4.80 $4.50 $4.73 5 152 256
Jun 01, 2020 $4.49 $4.77 $4.41 $4.69 7 221 613
May 29, 2020 $4.57 $4.63 $4.24 $4.50 8 719 515
May 28, 2020 $4.70 $4.86 $4.48 $4.50 17 140 615
May 27, 2020 $5.10 $5.12 $4.33 $5.04 9 339 516
May 26, 2020 $5.49 $5.53 $5.17 $5.20 8 013 319
May 22, 2020 $5.30 $5.47 $5.23 $5.45 3 605 346
May 21, 2020 $5.52 $5.54 $4.97 $5.35 8 861 051
May 20, 2020 $5.18 $5.64 $5.05 $5.61 12 610 827
May 19, 2020 $4.97 $5.23 $4.93 $5.10 7 771 790
May 18, 2020 $5.27 $5.37 $4.83 $4.93 11 425 501
May 15, 2020 $4.96 $5.37 $4.95 $5.29 7 258 023
May 14, 2020 $4.70 $5.25 $4.68 $5.08 9 800 869
May 13, 2020 $5.30 $5.50 $4.60 $4.90 16 262 871
May 12, 2020 $6.17 $6.29 $5.37 $5.41 23 453 066
May 11, 2020 $5.05 $5.67 $5.01 $5.54 24 353 626
May 08, 2020 $3.92 $4.78 $3.92 $4.70 21 134 358
May 07, 2020 $3.87 $4.00 $3.77 $3.92 8 412 636
Click to get the best stock tips daily for free!

About BioCryst Pharmaceuticals

BioCryst Pharmaceuticals BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor, which is in Phase II... BCRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT